These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 10843787)
1. The effects of highly selective opioid receptor antagonists on the release of arginine vasotocin induced by hyperosmotic stimulation and angiotensin II injection. Sasaki T; Arakawa K; Shimada K; Saito N Gen Comp Endocrinol; 2000 Jun; 118(3):365-72. PubMed ID: 10843787 [TBL] [Abstract][Full Text] [Related]
2. Effects of naloxone on neurohypophyseal peptide release by hypertonic stimulation in chicks. Saito N; Furuse M; Sasaki T; Arakawa K; Shimada K Gen Comp Endocrinol; 1999 Aug; 115(2):228-35. PubMed ID: 10417236 [TBL] [Abstract][Full Text] [Related]
3. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice. Baker AK; Meert TF J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687 [TBL] [Abstract][Full Text] [Related]
4. Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test. Makino M; Kitano Y; Komiyama C; Hirohashi M; Takasuna K Br J Pharmacol; 2000 Jul; 130(6):1269-74. PubMed ID: 10903965 [TBL] [Abstract][Full Text] [Related]
5. Conditioned immunomodulation: investigations of the role of endogenous activity at mu, kappa, and delta opioid receptor subtypes. Perez L; Lysle DT J Neuroimmunol; 1997 Nov; 79(2):101-12. PubMed ID: 9394782 [TBL] [Abstract][Full Text] [Related]
6. Regulation of opioid peptides on the release of arginine vasotocin in the hen. Sasaki T; Shimada K; Saito N J Exp Zool; 2000 Apr; 286(5):481-6. PubMed ID: 10684571 [TBL] [Abstract][Full Text] [Related]
7. Involvement of opioid receptors in the oxytocin-induced antinociception in the central nervous system of rats. Gao L; Yu LC Regul Pept; 2004 Aug; 120(1-3):53-8. PubMed ID: 15177920 [TBL] [Abstract][Full Text] [Related]
8. Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats. Negus SS; Henriksen SJ; Mattox A; Pasternak GW; Portoghese PS; Takemori AE; Weinger MB; Koob GF J Pharmacol Exp Ther; 1993 Jun; 265(3):1245-52. PubMed ID: 8389859 [TBL] [Abstract][Full Text] [Related]
9. Differential modulation of angiotensin II and hypertonic saline-induced drinking by opioid receptor subtype antagonists in rats. Ruegg H; Hahn B; Koch JE; Bodnar RJ Brain Res; 1994 Jan; 635(1-2):203-10. PubMed ID: 8173956 [TBL] [Abstract][Full Text] [Related]
10. Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: demonstration of an opioid kappa and delta inhibitory tone. Ossipov MH; Kovelowski CJ; Wheeler-Aceto H; Cowan A; Hunter JC; Lai J; Malan TP; Porreca F J Pharmacol Exp Ther; 1996 May; 277(2):784-8. PubMed ID: 8627559 [TBL] [Abstract][Full Text] [Related]
11. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model. Zhao M; Wang JY; Jia H; Tang JS Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416 [TBL] [Abstract][Full Text] [Related]
12. Involvement of mu- and kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine. Shahbazian A; Heinemann A; Schmidhammer H; Beubler E; Holzer-Petsche U; Holzer P Br J Pharmacol; 2002 Feb; 135(3):741-50. PubMed ID: 11834622 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety. Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975 [TBL] [Abstract][Full Text] [Related]
14. Functional interactions between delta- and mu-opioid receptors in rat thermoregulation. Salmi P; Kela J; Arvidsson U; Wahlestedt C Eur J Pharmacol; 2003 Jan; 458(1-2):101-6. PubMed ID: 12498912 [TBL] [Abstract][Full Text] [Related]
15. The opioid receptor subtypes mu and kappa, but not delta, are involved in the control of the vasopressin and oxytocin release in the rat. Van de Heijning BJ; Koekkoek-Van den Herik I; Van Wimersma Greidanus TB Eur J Pharmacol; 1991 Dec; 209(3):199-206. PubMed ID: 1665795 [TBL] [Abstract][Full Text] [Related]
16. Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Ciccocioppo R; Martin-Fardon R; Weiss F Neuropsychopharmacology; 2002 Sep; 27(3):391-9. PubMed ID: 12225696 [TBL] [Abstract][Full Text] [Related]
17. Different central opioid receptor subtype antagonists modify maltose dextrin and deprivation-induced water intake in sham feeding and sham drinking rats. Leventhal L; Bodnar RJ Brain Res; 1996 Nov; 741(1-2):300-8. PubMed ID: 9001736 [TBL] [Abstract][Full Text] [Related]
18. Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation. Nelson CJ; Schneider GM; Lysle DT Brain Behav Immun; 2000 Sep; 14(3):170-84. PubMed ID: 10970678 [TBL] [Abstract][Full Text] [Related]
19. Effects of mu-, delta- and kappa-opioid antagonists in atrial preparations from nonfailing and failing human hearts. Llobel F; Laorden ML Gen Pharmacol; 1997 Mar; 28(3):371-4. PubMed ID: 9068975 [TBL] [Abstract][Full Text] [Related]
20. Opioid receptor subtypes involved in the regulation of prolactin secretion during pregnancy and lactation. Andrews ZB; Grattan DR J Neuroendocrinol; 2003 Mar; 15(3):227-36. PubMed ID: 12588510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]